Go to SamhsaGo to CSAT
Go to U.S. Deparment of Health and Human ServicesBuprenorphine
HomeAbout BuprenorphineDrug Addiction Treatment Act of 2000Physician Waiver QualificationsWaiver NotificationFrequently Asked QuestionsPhysician LocatorDATA-Qualifying Physician Training EventsPhysician Buprenorphine CurriculumModel State Policy GuidelinesOther LinksFor More Information
CSAT Division of Pharmacologic TherapiesGo to Samhsa Resources


Buprenorphine Publications


Patient and Family BrochurePatient and Family Brochure, Introducing Office-Based Treatment for Opioid Addiction

Introducing Office-Based Treatment for Opioid Addiction is a new publication designed to provide patients and their families with important information about opioid addiction treatment with buprenorphine outside of the context of the traditional Opioid Treatment Program. The pamphlet provides an overview of buprenorphine and how it can be prescribed to treat addiction to opioids in the office-based setting. The brochure encourages patients to work with their health care provider to learn more about this new treatment.

The pamphlet is available free from the National Clearinghouse for Alcohol and Drug Information.




Draft Buprenorphine Curriculum for Physicians


The Draft Buprenorphine Curriculum for Physicians is based on the CSAT Buprenorphine Clinical Practice Guidelines (DRAFT), which is in the process of being updated and finalized. The Curriculum was developed by a consensus panel, which included members from the American Academy of Addiction Psychiatry, the American Osteopathic Academy of Addiction Medicine, and the American Society of Addiction Medicine. Development of the Curriculum was supported by CSAT.

The purpose of the Curriculum is to educate health care providers by providing tools that guide in the preparation of lectures and other medical education activities related to prescribing buprenorphine for the treatment of opioid addiction.

The Curriculum includes the core information unique to buprenorphine and its use in the pharmacological management of opioid addiction, as well as a comprehensive overview of treatment for opioid addiction. It does not describe a standard of care. Treatment decisions should be made based upon the individual patient and the level of available resources.



Note: the Curriculum is in DRAFT form and is currently being updated based on the recent FDA approval of Subutex® and Suboxone® for opioid therapy.

Click here to download the DRAFT Buprenorphine Curriculum for Physicians [PDF File, 2.1 Mb].Download Adobe Acrobat Reader To view and print this document, you will need to download Adobe Acrobat Reader.

    

Drug Addiction Treatment Act of 2000 | Physician Waiver Qualifications | Waiver Notification
Physician Locator | Frequently Asked Questions | For More Information | Buprenorphine Trainings

Home | Privacy Statement | Site Disclaimer | Accessibility